Country antimalarial drug policies: by region
- WHO African Region
- WHO Region of the Americas
- WHO South-East Asia Region
- WHO Eastern Mediterranean Region
- WHO Western Pacific Region
WHO European Region
| Global AMDP database - WHO European Region | ||||||||
| Last Updated: February 2011 | P. falciparum | P.vivax | ||||||
| COUNTRY/ AREA | SPECIES | uncomplicated | treatment failure | severe malaria | pregnancy | treatment | ||
| un- confirmed | lab- confirmed | treatment | prevention | |||||
| Armenia | vivax only | CQ+PQ(14d) | ||||||
| Azerbaijan | vivax only | CQ+PQ(14d) | ||||||
| Georgia | vivax only | CQ+PQ(14d) | ||||||
| Tajikistan | falciparum /vivax | AL | QN(7d) | QN(7d) | QN(7d) | CQ+PQ(14d) | ||
| Turkey | vivax only | CQ+PQ(14d) | ||||||
| Turkmenistan | vivax only | CQ+PQ(14d) | ||||||
AL=Artemether-lumefantrine
AS=Artesunate
CQ=Chloroquine
PQ=Primaquine
QN=Quinine
SP=Sulphadoxine-pyrimethamine